Tissue Regenix Group Plc
(LSE) TRX
Tissue Regenix Group Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$42.72M
Net Income (TTM)
$2.52M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tissue Regenix Group Plc
Industry
Biotechnology
Sector
Health CareCEO
Daniel R. Lee
Website
www.tissueregenix.comHeadquarters
Garforth, LS25 2GY, GB
TRX Financials
Key Financial Metrics (TTM)
Gross Margin
42%
Operating Margin
-4%
Net Income Margin
-7%
Return on Equity
-3%
Return on Capital
-1%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$13.62M
Operating Income
$349.00K
EBITDA
$1.36M
Operating Cash Flow
$1.64M
Capital Expenditure
$4.07M
Free Cash Flow
$5.70M
Cash & ST Invst.
$1.87M
Total Debt
$10.46M
Tissue Regenix Group Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.80M
+28.2%
Gross Profit
$5.77M
+16.1%
Gross Margin
41.82%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
82
N/A
Net Income
$934.00K
-0.5%
EBITDA
$5.00K
+102.7%
Quarterly Fundamentals
Net Cash
$9.92M
-132.2%
Accounts Receivable
$4.12M
-4.7%
Inventory
$16.70M
+86.9%
Long Term Debt
$10.43M
+45.6%
Short Term Debt
$569.00K
+44.8%
Return on Assets
-1.98%
N/A
Return on Invested Capital
-1.24%
N/A
Free Cash Flow
$252.00K
+81.1%
Operating Cash Flow
$202.00K
+79.3%